Picton Mahoney Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Picton Mahoney Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-386,135	Closed	-$7.7M	–	863
2022 Q3	$7.7M	Buy	+386,135	New	+$5.09M	0.28%	75

Picton Mahoney Asset Management's FMTX Position: Q4 2022 in Review

Picton Mahoney Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 386,135 shares — an estimated $7.7M sold.

Picton Mahoney Asset Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $7.7M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Picton Mahoney Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 386,135 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $7.7M.
Picton Mahoney Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Picton Mahoney Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $7.7M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.